Type 2 Diabetes

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
What is Type 2 Diabetes?

Type 2 diabetes is a common metabolic condition that develops when the body fails to produce enough insulin or when insulin fails to work properly, which is referred to as insulin resistance. Insulin is the hormone that stimulates cells to uptake glucose from the blood to use for energy.

Read More

Overview

Feature Articles

Latest Type 2 Diabetes News and Research

Virtual diabetes self-management interventions improve blood sugar levels

Virtual diabetes self-management interventions improve blood sugar levels

Rare sugars curb appetite and mimic diabetes drugs in mice

Rare sugars curb appetite and mimic diabetes drugs in mice

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

UVA Health experts highlight a growing array of treatment options for type 2 diabetes

UVA Health experts highlight a growing array of treatment options for type 2 diabetes

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Eating ultra-processed food daily increases depression risk in older adults

Eating ultra-processed food daily increases depression risk in older adults

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

High blood pressure can lead to structural changes in the kidneys

High blood pressure can lead to structural changes in the kidneys

Wearable technologies may improve exercise adherence in people with Type 2 Diabetes

Wearable technologies may improve exercise adherence in people with Type 2 Diabetes

Pass the (iodized) salt: Iodine deficiency drives frailty risk in people with diabetes

Pass the (iodized) salt: Iodine deficiency drives frailty risk in people with diabetes

Flavonoids help regulate gut hormones and show promise in managing type 2 diabetes

Flavonoids help regulate gut hormones and show promise in managing type 2 diabetes

Scientists link emulsifiers in processed foods to allergy and immune disorders

Scientists link emulsifiers in processed foods to allergy and immune disorders

Addressing cardiovascular risk factors in emerging adulthood

Addressing cardiovascular risk factors in emerging adulthood

Early antibiotic exposure may boost risk of diabetes later in life

Early antibiotic exposure may boost risk of diabetes later in life

Anti-inflammatory drugs may reduce metabolic disease risk by inhibiting the sweet taste receptor

Anti-inflammatory drugs may reduce metabolic disease risk by inhibiting the sweet taste receptor

The best diet for aging well, backed by a 30-year study of 100,000 people

The best diet for aging well, backed by a 30-year study of 100,000 people

Study links type 2 diabetes to weakened reward signals in the brain

Study links type 2 diabetes to weakened reward signals in the brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.